Enliven Therapeutics, Inc. SEC filings ELVN
Enliven Therapeutics, Inc. has 798 filings in SEC EDGAR's recent list, going back to Apr 21, 2016. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 14, 2026 | Oct 14, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 12, 2026 | Jun 11, 2026 |
| 424B5 | Prospectus supplement | Jun 12, 2026 | — |
| 424B5 | Prospectus supplement | Jun 11, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 11, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 10, 2026 | Jun 9, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| ARS | Annual report to shareholders | Apr 27, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 27, 2026 | — |
| DEF 14A | Proxy statement | Apr 27, 2026 | Jun 9, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2026 | Jun 9, 2026 |
| S-8 | Employee stock plan registration | Mar 3, 2026 | — |
| 10-K | Annual report | Mar 3, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2026 | Mar 3, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 7, 2026 | Jan 6, 2026 |
| S-8 | Employee stock plan registration | Dec 16, 2025 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 11, 2025 | Dec 9, 2025 |
| 8-K/A |
Amended current report
Results of operations
|
Nov 13, 2025 | Nov 12, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| S-3ASR | Automatic shelf registration | Aug 13, 2025 | — |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 25, 2025 | Jun 24, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 16, 2025 | Jun 13, 2025 |
| 424B5 | Prospectus supplement | Jun 16, 2025 | — |
| S-3MEF | Filing | Jun 13, 2025 | — |
| 424B5 | Prospectus supplement | Jun 13, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 13, 2025 | Jun 13, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| ARS | Annual report to shareholders | Apr 28, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 28, 2025 | — |
| DEF 14A | Proxy statement | Apr 28, 2025 | Jun 24, 2025 |
| S-8 | Employee stock plan registration | Mar 13, 2025 | — |
| 10-K | Annual report | Mar 13, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2025 | Mar 13, 2025 |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| S-8 | Employee stock plan registration | Jun 20, 2024 | — |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 18, 2024 | Jun 18, 2024 |
| 8-K/A |
Amended current report
Officer or director change
|
May 29, 2024 | Apr 8, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| EFFECT | Filing | Apr 30, 2024 | — |
| 424B3 | Prospectus | Apr 30, 2024 | — |
| CORRESP | Letter to the SEC | Apr 26, 2024 | — |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 18, 2024 |
| UPLOAD | Letter from the SEC | Apr 24, 2024 | — |
| CORRESP | Letter to the SEC | Apr 18, 2024 | — |
| S-3 | Shelf registration | Apr 18, 2024 | — |
| PRE 14A | Preliminary proxy statement | Apr 15, 2024 | Jun 18, 2024 |
| 8-K |
Current report
Other events
|
Apr 11, 2024 | Apr 11, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 9, 2024 | Apr 8, 2024 |
| D | Filing | Apr 3, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Mar 19, 2024 | Mar 19, 2024 |
| S-8 | Employee stock plan registration | Mar 14, 2024 | — |
| 10-K | Annual report | Mar 14, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 14, 2024 | Mar 14, 2024 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 424B5 | Prospectus supplement | Jul 6, 2023 | — |
| EFFECT | Filing | Jul 3, 2023 | — |
| CORRESP | Letter to the SEC | Jun 29, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 29, 2023 | — |
| 8-K |
Current report
Material agreement, Agreement ended
|
Jun 26, 2023 | Jun 23, 2023 |
| S-3 | Shelf registration | Jun 23, 2023 | — |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 23, 2023 | Jun 23, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 23, 2023 |
| 8-K/A |
Amended current report
Regulation FD disclosure, Other events
|
Mar 21, 2023 | Feb 23, 2023 |
| S-8 | Employee stock plan registration | Mar 1, 2023 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Other events
|
Mar 1, 2023 | Feb 23, 2023 |
| 425 | Filing | Feb 22, 2023 | — |
| 8-K |
Current report
Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Feb 22, 2023 | Feb 22, 2023 |
| 425 | Filing | Feb 13, 2023 | — |
| 8-K |
Current report
Other events
|
Feb 13, 2023 | Feb 13, 2023 |
| 10-K | Annual report | Feb 10, 2023 | Dec 31, 2022 |
| EFFECT | Filing | Jan 23, 2023 | — |
| 424B3 | Prospectus | Jan 23, 2023 | — |
| CORRESP | Letter to the SEC | Jan 19, 2023 | — |
| S-4/A | Filing | Jan 9, 2023 | — |
| CORRESP | Letter to the SEC | Jan 6, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 29, 2022 | — |
| CORRESP | Letter to the SEC | Dec 19, 2022 | — |
| S-4/A | Filing | Dec 19, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 7, 2022 | — |
| 425 | Filing | Dec 5, 2022 | — |
| 8-K |
Current report
Other events
|
Dec 5, 2022 | Nov 28, 2022 |
| 8-K/A | Amended current report | Nov 16, 2022 | Nov 10, 2022 |
| S-4 | Registration for a merger or exchange | Nov 10, 2022 | — |
| 8-K |
Current report
Acquisition or sale of assets, Shareholder vote results
|
Nov 10, 2022 | Nov 9, 2022 |
| 10-Q | Quarterly report | Oct 25, 2022 | Sep 30, 2022 |
| DEFA14A | Additional proxy material | Oct 19, 2022 | — |
| 425 | Filing | Oct 14, 2022 | — |
| 8-K |
Current report
Other events
|
Oct 14, 2022 | Oct 13, 2022 |
| 425 | Filing | Oct 13, 2022 | — |
| 8-K |
Current report
Material agreement, Other events
|
Oct 13, 2022 | Oct 13, 2022 |
| DEFM14A | Filing | Oct 7, 2022 | — |
| PREM14A | Filing | Sep 23, 2022 | Sep 23, 2022 |
| DEFA14A | Additional proxy material | Sep 7, 2022 | — |
| 8-K |
Current report
Material agreement, Officer or director change, Other events
|
Sep 7, 2022 | Sep 6, 2022 |
| 10-Q | Quarterly report | Aug 3, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Jul 29, 2022 | Jul 25, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2022 | Jun 2, 2022 |
| 10-Q | Quarterly report | May 6, 2022 | Mar 31, 2022 |
| DEFA14A | Additional proxy material | Apr 22, 2022 | — |
| DEF 14A | Proxy statement | Apr 22, 2022 | Jun 2, 2022 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change, Other events
|
Apr 14, 2022 | Apr 5, 2022 |
| 424B5 | Prospectus supplement | Mar 15, 2022 | — |
| S-8 | Employee stock plan registration | Mar 15, 2022 | — |
| 10-K | Annual report | Mar 15, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 15, 2022 | Mar 15, 2022 |
| 10-Q | Quarterly report | Nov 9, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2021 | Nov 9, 2021 |
| 8-K |
Current report
Officer or director change
|
Oct 25, 2021 | Oct 21, 2021 |
| S-8 | Employee stock plan registration | Aug 6, 2021 | — |
| 10-Q | Quarterly report | Aug 6, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2021 | Aug 6, 2021 |
| 424B5 | Prospectus supplement | Jul 14, 2021 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jul 14, 2021 | Jul 13, 2021 |
| 424B5 | Prospectus supplement | Jul 13, 2021 | — |
| 8-K |
Current report
Other events
|
Jul 13, 2021 | Jul 13, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 30, 2021 | Jun 29, 2021 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Jun 11, 2021 | Jun 8, 2021 |
| DEFA14A | Additional proxy material | May 18, 2021 | — |
| DEF 14A | Proxy statement | May 18, 2021 | Jun 29, 2021 |
| 10-Q | Quarterly report | May 11, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 11, 2021 | May 11, 2021 |
| EFFECT | Filing | Apr 8, 2021 | — |
| CORRESP | Letter to the SEC | Apr 6, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 6, 2021 | — |
| 8-K |
Current report
Material agreement
|
Apr 1, 2021 | Apr 1, 2021 |
| S-3 | Shelf registration | Apr 1, 2021 | — |
| 10-K | Annual report | Mar 5, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 5, 2021 | Mar 5, 2021 |
| 10-Q | Quarterly report | Nov 5, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| 10-Q | Quarterly report | Aug 14, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2020 | Aug 14, 2020 |
| 10-Q | Quarterly report | May 7, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
May 7, 2020 | May 7, 2020 |
| 8-K |
Current report
Officer or director change
|
Apr 23, 2020 | Apr 22, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 16, 2020 | Mar 16, 2020 |
| S-8 | Employee stock plan registration | Mar 12, 2020 | — |
| 424B4 | Prospectus | Mar 12, 2020 | — |
| EFFECT | Filing | Mar 11, 2020 | — |
| CERT | Filing | Mar 11, 2020 | — |
| CORRESP | Letter to the SEC | Mar 10, 2020 | — |
| S-1/A | Amended registration statement | Mar 10, 2020 | — |
| 8-A12B | Filing | Mar 9, 2020 | — |
| CORRESP | Letter to the SEC | Mar 9, 2020 | — |
| CORRESP | Letter to the SEC | Mar 9, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 9, 2020 | — |
| S-1/A | Amended registration statement | Mar 3, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 24, 2020 | — |
| CORRESP | Letter to the SEC | Feb 19, 2020 | — |
| CORRESP | Letter to the SEC | Feb 14, 2020 | — |
| S-1 | Registration statement | Feb 14, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 16, 2019 | — |
| DRSLTR | Filing | Oct 8, 2019 | — |
| DRS/A | Filing | Oct 8, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 11, 2019 | — |
| SEC STAFF LETTER | Filing | Sep 10, 2019 | — |
| DRS | Filing | Aug 15, 2019 | — |
| D | Filing | Mar 29, 2019 | — |
| D | Filing | Apr 21, 2016 | — |
Showing 181 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ELVN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Burlingame, CA
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1672619
- Former names
- IMARA Inc. (until Feb 23, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.